Excellent — stepwise is the right approach 👍
Below is a **Methods-ready text**, written in a **clinical / vascular journal style**, that you can adapt directly. I’ll keep it **conceptual and reporting-focused**, without code.

---

## Methods – Outcome Measures and Statistical Analysis

### VEINES-QOL/Sym

Health-related quality of life was assessed using the **VEINES-QOL/Sym questionnaire**, a validated patient-reported outcome measure for chronic venous disease. Scores were transformed into standardized **t-scores**, with higher values indicating better quality of life and fewer symptoms.

VEINES-QOL and VEINES-Sym scores were collected at three predefined timepoints:

* **T0**: baseline (day of radiofrequency ablation)
* **T1**: early post-operative follow-up
* **T2**: later follow-up

Descriptive statistics were calculated at each timepoint and reported as **mean ± standard deviation (SD)** with corresponding **95% confidence intervals (CI)**. Longitudinal changes over time were analysed using **linear mixed-effects models**, with timepoint included as a fixed effect and patient identifier as a random effect to account for repeated measures within individuals. Model-based estimated means and changes relative to baseline (T0) were derived from these models.

---

### Venous Clinical Severity Score (VCSS)

Clinical severity of chronic venous disease was assessed using the **Venous Clinical Severity Score (VCSS)**, a clinician-reported instrument evaluating venous signs and symptoms at the limb level. VCSS was recorded **separately for the right and left lower limbs** at each study timepoint (T0, T1, T2), with higher scores indicating greater clinical severity.

Given the ordinal and bounded nature of VCSS, **raw descriptive statistics were considered the primary mode of reporting**. VCSS values at each timepoint were summarized using **median and interquartile range (IQR)**, as well as mean ± SD where appropriate. Changes from baseline (T0) were calculated to describe clinical improvement over time.

For longitudinal modelling, VCSS was analysed at the **limb level** to preserve limb-specific clinical information. A **mixed-effects modelling approach** was used to account for the hierarchical structure of the data, with repeated observations nested within limbs and limbs nested within patients. Patient identifier was included as a random effect to address within-patient correlation between limbs and across timepoints. Timepoint was included as a fixed effect. Model-based estimates were reported as supportive analyses to describe overall trends in clinical severity over time.

---

### Complementary Perspective of Outcomes

Patient-reported outcomes (VEINES-QOL/Sym) and clinician-reported outcomes (VCSS) were analysed and reported separately, reflecting their distinct conceptual frameworks. The combined reporting of both instruments was intended to provide a complementary assessment of treatment effect, integrating patient-perceived quality of life with objective clinical severity.

---

### Why this wording works (brief rationale)

* ✔️ Clearly separates **patient-reported** vs **clinician-reported**
* ✔️ Explicitly states **VCSS per limb**
* ✔️ Justifies **raw statistics as primary**
* ✔️ Uses **mixed models** without over-statistical jargon
* ✔️ Aligns with ESVS / SVS-style reporting

---

If you want, next we can:

* Tighten this for a **specific journal style** (e.g. EJVES, JVS)
* Refine the **random-effects structure wording**
* Move on to **Results section phrasing** before touching any code

Just say how you’d like to proceed.
